Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Mersana Therapeutics Inc
0M4Current price
2.29 EUR
-0.12 EUR (-4.86%)
Last closed
2.63 USD
Company
www.mersana.com
ISIN
US59045L1061
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
315 274 752 USD
Yield for 12 month
+63.64 %
1Y
3Y
5Y
10Y
15Y
0M4
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts. Address: 840 Memorial Drive, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.5 USDP/E ratio
–Dividend Yield
–Current Year
+36 855 000 USD
Last Year
+26 581 000 USD
Current Quarter
+2 293 000 USD
Last Quarter
+9 245 000 USD
Current Year
+35 338 000 USD
Last Year
+25 654 000 USD
Current Quarter
+1 890 000 USD
Last Quarter
+8 822 000 USD
Key Figures 0M4
1 year
3 years
5 years
10 years
EBITDA
-101 411 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.3 %
PEG Ratio
–
Return On Equity TTM
-213.33 %
Wall Street Target Price
6.5 USD
Revenue TTM
29 937 000 USD
Book Value
0.069 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-78.5 %
Dividend Yield
–
Gross Profit TTM
-146 804 000 USD
Earnings per share
-0.85 USD
Diluted Eps TTM
-0.85 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0M4
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0M4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 0M4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.1743
Price Sales TTM
10.5313
Enterprise Value EBITDA
-2.2011
Price Book MRQ
37.4125
Financials 0M4
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0M4
For 52 weeks
1.22 USD
6.28 USD
50 Day MA
1.94 USD
Shares Short Prior Month
9 531 634
200 Day MA
2.75 USD
Short Ratio
9.74
Shares Short
9 971 400
Short Percent
10.69 %
BeatStart